Science recently revealed the Science 2017 Top Employer results.
It has been 15 years since the first Top Employers Survey conducted by Science took place, targeting biotechnology, biopharmaceuticals, pharmaceuticals companies. The survey evaluates companies from financial strength, agility, and R&D. Each company’s final rankings are based on a number of factors, including the status of industry innovations, whether the corporate culture values are in line with the employee's personal values, and whether employees are respected. Social responsibility is also counted.
Recently, Science announced the Science 2017 Top Employer. Regeneron Pharmaceuticals (USA), Novozymes (Denmark) and Vertex Pharma (USA) ranked the top three in the list. Top 10 list includes: Merck KGaA (Denmark), Novo Nordisk (Denmark), Moderna Therapeutics (USA), Genentech (USA), Eli Lilly (USA), Biocon (India), AbbVie (USA).
It is worth mentioning that, Regeneron Pharmaceuticals ranked first or second for seven years, during which ranking first for five years (2017, 2016, 2014, 2013 and 2012) and second for two years (2015 and 2011), becoming the highest ranked company in the past 10 years. And AstraZeneca re-entered the list six years after its departure and the company's last entry was in 2011, ranking 19th.
In 2017, nearly 7,000 respondents answered the online survey, the highest in 15 years. As in previous years, respondents ranked enterprise innovation, a positive work culture and social responsibility as the top factors in evaluating the best employers. Emphasis was also placed on enterprises' broad support for science education.
The survey feedback data statistics are as follows:
Gender: male (52%), female (43%), unselected (5%);
Highest degree: PhD (34%), Master (30%), undergraduate (29%), others (7%);
Work experience: 10 years and above work experience (69%);
Company type: pharmaceuticals (35%), biotechnology (23%), biopharmaceutical (36%), university (1%), others (5%); private sector employees (over 90%);
Function: Development (28%), Applied research (19%), Basic research (14%), Administration (8%), QA / QC / RA (7%), other (13%); (Note: the invited staff can chose more than one).
Geographic region: North America (65%), Europe (25%), Asia / Pacific Rim (7%), others (3%).
ELife: T Interferon Suppresses Inflammatory Diseases by Balancing the Microbiome
Study found that STAT1KO mice spontaneously develop inflammatory diseases characterized by bone marrow hyperplasia and splenic accumulation of hematopoietic stem cells.
Proteins That Provide Key Information to Identify Patients with Poor Prognosis Found
Specific patterns or "signatures" of markers on the surface of immune cells in the blood may be biomarkers of immune checkpoint immunotherapy response, study found.
New Findings about BRD4 Protein You May Want to Know
How BRD4 (a protein that scientists have studied for many years) directs the spatial organization of DNA in the cell nucleus (a key function of stem cells to differentiate into muscle cells) has been clarified by a new study.
